[English] 日本語
Yorodumi- PDB-21aa: Structure of Human Aspartate--tRNA ligase 3-154 with linker and F... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 21aa | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Structure of Human Aspartate--tRNA ligase 3-154 with linker and FC : ATYR0101 | |||||||||
Components | Aspartate--tRNA ligase, cytoplasmic,linker+FC | |||||||||
Keywords | APOPTOSIS / Fibrosis / t-RNA synthase / Myofibroblast | |||||||||
| Function / homology | Function and homology informationaminoacylase activity / aspartate-tRNA ligase / aspartate-tRNA ligase activity / aspartyl-tRNA aminoacylation / Selenoamino acid metabolism / Cytosolic tRNA aminoacylation / aminoacyl-tRNA synthetase multienzyme complex / tRNA aminoacylation for protein translation / Transcriptional and post-translational regulation of MITF-M expression and activity / protein-containing complex assembly ...aminoacylase activity / aspartate-tRNA ligase / aspartate-tRNA ligase activity / aspartyl-tRNA aminoacylation / Selenoamino acid metabolism / Cytosolic tRNA aminoacylation / aminoacyl-tRNA synthetase multienzyme complex / tRNA aminoacylation for protein translation / Transcriptional and post-translational regulation of MITF-M expression and activity / protein-containing complex assembly / translation / synapse / RNA binding / extracellular exosome / ATP binding / membrane / cytosol / cytoplasm Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 4.96 Å | |||||||||
Authors | Nangle, L. / Tian, H. / Fung, C.P. | |||||||||
| Funding support | Hong Kong, 1items
| |||||||||
Citation | Journal: J Biol Chem / Year: 2026Title: Natural Asp-tRNA Synthetase Fragment Targets Myofibroblasts to Abrogate Tissue Fibrosis. Authors: Ryan A Adams / Ying-Ting Wang / Alison G Barber / Kristina Hamel / Andrew Imfeld / Luke Burman / Kaitlyn Rauch / Yeeting E Chong / Angelica Villanueva / Lauren Guy / Wayne Liu / Crystal ...Authors: Ryan A Adams / Ying-Ting Wang / Alison G Barber / Kristina Hamel / Andrew Imfeld / Luke Burman / Kaitlyn Rauch / Yeeting E Chong / Angelica Villanueva / Lauren Guy / Wayne Liu / Crystal Manzo / Sofia Klopp-Savino / Clara Polizzi / Jasmine Stamps / Max Pastenes / Honglei Tian / Chun Po Fung / Yingyi Zhang / Kwok Wa Hugo Ho / Bruno Sangiorgi / Blythe Dillingham / Tarsis F Brust / Kyle P Chiang / Zhenguo Wu / Zhiwen Xu / Christoph Burkart / Leslie A Nangle / ![]() Abstract: Fibrosis remains a major global health challenge with limited therapies that only slow disease progression. While the aminoacyl-tRNA synthetase (aaRS) family is known to utilize evolutionarily ...Fibrosis remains a major global health challenge with limited therapies that only slow disease progression. While the aminoacyl-tRNA synthetase (aaRS) family is known to utilize evolutionarily appended domains as extracellular signaling molecules, their role in regulating the homeostasis of the fibrotic process is poorly defined. We identify a natural proteolytic fragment of aspartyl-tRNA synthetase (DARS), termed DARS-N1, that selectively triggers apoptosis in myofibroblasts by targeting latent-transforming growth factor beta binding protein 1 (LTBP-1) on the extracellular matrix (ECM). This active N-terminal fragment of DARS reduces focal adhesion kinase (FAK) activation in undifferentiated fibroblasts and myofibroblasts, while only myofibroblasts exhibit inadequate cell-matrix attachment leading to loss of anchorage-dependent survival and promotion of apoptosis. We utilized ATYR0101, a therapeutic form of DARS-N1 engineered for extended serum exposure, to demonstrate anti-fibrotic activity in lung (bleomycin). Spatial transcriptomics analysis showed that ATYR0101 activates a restorative program promoting the return to a healthy state. These findings highlight ATYR0101's potential as a transformative therapy for disrupting the process of chronic tissue fibrosis. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 21aa.cif.gz | 261.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb21aa.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 21aa.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/1a/21aa ftp://data.pdbj.org/pub/pdb/validation_reports/1a/21aa | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 67441MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 45527.676 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Details: N-terminal portion is flexible random loop and not visible in structure,N-terminal portion is flexible random loop and not visible in structure Source: (gene. exp.) Homo sapiens (human) / Gene: DARS1, DARS, PIG40 / Cell line (production host): Expi293F / Production host: Homo sapiens (human) / References: UniProt: P14868, aspartate-tRNA ligaseHas protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Human Aspartate--tRNA ligase 3-154: -Linker-Fcv14 / Type: COMPLEX Details: Recombinant protein of N-terminal of Human Aspartate tRNA ligase and IgG FC Entity ID: all / Source: RECOMBINANT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Experimental value: NO | ||||||||||||
| Source (natural) |
| ||||||||||||
| Source (recombinant) | Organism: Homo sapiens (human) / Cell: Expi293F | ||||||||||||
| Buffer solution | pH: 7.4 / Details: 1x PBS 7.4 | ||||||||||||
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES / Details: This sample is purified from Expi293F expression | ||||||||||||
| Specimen support | Grid material: COPPER / Grid type: Quantifoil R1.2/1.3 | ||||||||||||
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 100 % / Chamber temperature: 291.15 K Details: To prepare cryo-grids, 3 ul samples were applied to glow discharged Quantifoil Cu grids (R1.2/1.3), which were subsequently blotted with filter paper (Ted Pella) for 3 seconds at 18oC and ...Details: To prepare cryo-grids, 3 ul samples were applied to glow discharged Quantifoil Cu grids (R1.2/1.3), which were subsequently blotted with filter paper (Ted Pella) for 3 seconds at 18oC and 100% humidity. The grids were immediately plunge frozen in liquid ethane using a FEI Vitrobot IV (ThermoFisher) |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: OTHER / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: OTHER / Nominal defocus max: 2500 nm / Nominal defocus min: 1200 nm |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: FEI FALCON III (4k x 4k) / Num. of real images: 1414 Details: A total of 1,508 movies were acquired and imported into Cryo-SPARC using the following parameters: Raw pixel size 1.06 A, Accelerating Voltage 300 kV, Spherical Aberration 2.7 mm, and Total ...Details: A total of 1,508 movies were acquired and imported into Cryo-SPARC using the following parameters: Raw pixel size 1.06 A, Accelerating Voltage 300 kV, Spherical Aberration 2.7 mm, and Total exposure dose 50 e/A^2. Motion correction and CTF estimation were performed using Full-frame Motion Correction and Patch CTF. After that, 1,414 micrographs were selected from the 1,508 micrographs based on average intensity |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| Particle selection | Details: After Inspect Particle Picks (NCC score > 0.670, 10 < local power score < 59) and Extract From Micrographs (Extraction box size 200 pix), a total of 2,771,298 particles were extracted | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 4.96 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 142250 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: AB INITIO MODEL / Space: REAL Details: Initial local fitting was done using Chimera X, followed by manual fitting using Coot. Finally it was refined using Phenix real space refinement | ||||||||||||||||||||||||
| Atomic model building | Details: Intial model of st / Source name: AlphaFold / Type: in silico model | ||||||||||||||||||||||||
| Refinement | Highest resolution: 4.96 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
Hong Kong, 1items
Citation


PDBj



